Form D Explorer

Inspect source fieldsReport a record issue

Form D — Outlook Therapeutics, Inc.

0001231919-25-000018 · filed Jan 27, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$31,977,359
Reported amount sold
$0
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Outlook Therapeutics, Inc.
CIK
1649989
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
111 S. WOOD AVENUE
ISELIN, NJ 08830
Phone
6096193990

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗